Old Web
English
Sign In
Acemap
>
authorDetail
>
Lingqin Yuan
Lingqin Yuan
Shandong University
Medicine
Cancer research
Glutaminase
Oncology
Internal medicine
4
Papers
29
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The Glutaminase Inhibitor Compound 968 Exhibits Potent in vitro and in vivo anti-tumor Effects in Endometrial Cancer
2020
Lingqin Yuan
Hui Guo
Guoyou Pan
Cong Wang
Dapeng Li
Naifu Liu
Ling Wei
Peipei Li
Xiugui Sheng
Show All
Source
Cite
Save
Citations (0)
Postoperative adjuvant chemotherapy combined with intracavitary brachytherapy achieved the equivalent survival compared with concurrent chemoradiotherapy in cervical cancer patients with intermediate-risk
2019
Japanese Journal of Clinical Oncology
Hao Yu
Linlin Zhang
Dapeng Li
Naifu Liu
Yueju Yin
Lu Zhang
Lingqin Yuan
Ming Liu
Xiugui Sheng
Show All
Source
Cite
Save
Citations (1)
Glutaminase inhibitor compound 968 inhibits cell proliferation and sensitizes paclitaxel in ovarian cancer.
2016
American Journal of Translational Research
Lingqin Yuan
Xiugui Sheng
Leslie H. Clark
Lu Zhang
Hui Guo
Hannah M. Jones
Adam K. Willson
Paola A. Gehrig
Chunxiao Zhou
Victoria L. Bae Jump
Show All
Source
Cite
Save
Citations (28)
Study on the relationship between the Polycomb Repressor Complex 2 protein complex core protein EZH2 and triple negative breast cancer
2015
Lingqin Yuan
Rong Zhang
Show All
Source
Cite
Save
Citations (0)
1